Neurological Complications of Covid-19: Review of Literature and Own Experience

Abnormal Serum Biochemical Results and Mitochondrial Damage of Lymphocytes in Patients with Schizophrenia and SARS-CoV-2 Infection: A Retrospective Study

“… 15–19 Besides, mitochondrial therapy can be used to alleviate neurological complications during the COVID-19 pandemic. 20 However, there is still a lack of clinical data on whether mitochondria are therapeutic targets for schizophrenia patients with SARS-CoV-2 infection. To effectively prioritize resources for schizophrenia patients, the identification of clinical and laboratory biochemical markers is urgently needed.…”